DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 07 · Volume 46 · November 2013 DOI: 10.1055/s-003-25868

Original Paper

225
Tamura, A.; Maruyama, Y.; Ishitobi, Y.; Kawano, A.; Ando, T.; Ikeda, R.; Inoue, A.; Imanaga, J.; Okamoto, S.; Kanehisa, M.; Ninomiya, T.; Tanaka, Y.; Tsuru, J.; Akiyoshi, J.: Salivary alpha-Amylase and Cortisol Responsiveness Following Electrical Stimulation Stress in Patients with the Generalized Type of Social Anxiety Disorder
261
Ostad Haji, E.; Tadic, A.; Wagner, S.; Dragivevic, A.; Müller, M. J.; Boland, K.; Rao, M. L.; Fric, M.; Laux, G.; Hiemke, C.: Early Improvement and Serum Concentrations of Citalopram to Predict Antidepressant Drug Response of Patients with Major Depression
267
Richards, M.; Chiba, S.; Ninomiya, M.; Wakabayasi, C.; Kunugi, H.: Inhibition of Olanzapine-Induced Weight Gain by the Retinoid Analog AM-80
Supplementary information
274
Abdullah-Koolmees, H.; Gardarsdottir, H.; Stoker, L. J.; Vuyk, J.; Egberts, T. C. G.; Heerdink, E. R.: Prevalence of Medication Use for Somatic Disease in Institutionalized Psychiatric Patients
Supplementary information
281
Lee, Y.; Lin, P.-Y.; Chang, Y.-Y.; Chong, M.-Y.; Cheng, A. T.: Antidepressant-induced Tardive Syndrome: a Retrospective Epidemiological Study
286
Spencer, J. R.; Chohan, T. W.; Karl, T.; Arnold, J. C.: Female Neuregulin 1 Heterozygous Mice Require Repeated Exposure to Δ9-Tetrahydrocannabinol to Alter Sensorimotor Gating Function

Letter to the Editor

292
Wielopolski, J.; Reich, K.; Clepce, M.; Kornhuber, J.; Thuerauf, N.: Long-term Use of Flupirtine Leads to Withdrawal Symptoms and is Associated with Dependency